Complement factor H 402His variant confers an increased mortality risk in Finnish nonagenarians: The Vitality 90+ study

Experimental Gerontology

Volumn 44, Issue 4, 2009, Pages 297-299

  Jylhävä, Juulia ^a   Eklund, Carita ^a   Jylhä, Marja ^b   Hervonen, Antti ^b   Lehtimäki, Terho ^c   Karhunen, Pekka ^a   Hurme, Mikko ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Complement factor H; Inflammation; Longevity; Mortality; Nonagenarians

Indexed keywords

COMPLEMENT FACTOR H;

AGING; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DOWN REGULATION; FEMALE; FINLAND; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE;

AGED, 80 AND OVER; AGING; COMPLEMENT FACTOR H; FEMALE; GENETIC VARIATION; HUMANS; INFLAMMATION MEDIATORS; LONGEVITY; MALE; POLYMORPHISM, GENETIC;

EID: 62349096447     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2008.10.006     Document Type: Article

References (16)

1. Balistreri C.R., Candore G., Colonna-Romano G., Lio D., Caruso M., Hoffmann E., Franceschi C., and Caruso C. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292 (2004) 2339-2340
2. Bonafe M., Olivieri F., Cavallone L., Giovagnetti S., Mayegiani F., Cardelli M., Pieri C., Marra M., Antonicelli R., Lisa R., Rizzo M.R., Paolisso G., Monti D., and Franceschi C. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 31 (2001) 2357-2361
3. Budovsky A., Abramovich A., Cohen R., Chalifa-Caspi V., and Fraifeld V. Longevity network: construction and implications. Mech. Ageing Dev. 128 (2007) 117-124
4. Christensen K., Johnson T.E., and Vaupel J.W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7 (2006) 436-448
5. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
6. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., and Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007) 92-105
7. Goebeler S., Jylhä M., and Hervonen A. Medical history, cognitive status and mobility at the age of 90. A population-based study in Tampere, Finland. Aging Clin. Exp. Res. 15 (2003) 154-161
8. Hurme M., Kivimäki M., Pertovaara M., Lehtimäki T., Karhunen P.J., Jylhä M., Hervonen A., and Eklund C. CRP gene is involved in the regulation of human longevity: a follow-up study in Finnish nonagenarians. Mech. Ageing Dev. 128 (2007) 574-576
9. Hurme M., Lehtimäki T., Jylhä M., Karhunen P.J., and Hervonen A. Interleukin-6 -174G/C polymorphism and longevity: a follow-up study. Mech. Ageing Dev. 126 (2005) 417-418
10. Jylhä M., Paavilainen P., Lehtimäki T., Goebeler S., Karhunen P.J., Hervonen A., and Hurme M. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007) 1016-1021
11. Laine M., Jarva H., Seitsonen S., Haapasalo K., Lehtinen M.J., Lindeman N., Anderson D.H., Johnson P.T., Järvelä I., Jokiranta T.S., Hageman G.S., Immonen I., and Meri S. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J. Immunol. 178 (2007) 3831-3836
12. Mooijaart S.P., Koeijvoets K.M., Sijbrands E.J., Daha M.R., and Westendorp R.G. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large. Exp. Gerontol. 42 (2007) 1116-1122
13. Rea I.M., McKeown P.P., McMaster D., Young I.S., Patterson C., Savage M.J., Belton C., Marchegiani F., Olivieri F., Bonafe M., and Franceschi C. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp. Gerontol. 39 (2004) 629-635
14. Skerka C., Lauer N., Weinberger A.A., Keilhauer C.N., Suhnel J., Smith R., Schlotzer-Schrehardt U., Fritsche L., Heinen S., Hartmann A., Weber B.H., and Zipfel P.F. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol. Immunol. 44 (2007) 3398-3406
15. Thakkinstian A., Han P., McEvoy M., Smith W., Hoh J., Magnusson K., Zhang K., and Attia J. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum. Mol. Genet. 15 (2006) 2784-2790
16. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listi F., Nuzzo D., Lio D., and Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 128 (2007) 83-91